Generic isotretinoin: a new risk for unborn children.
Koren
Gideon
G
Motherisk program, Division of Clinical Pharmacology, The Hospital for Sick Children and Sunnybrook and Women's College Health Sciences Centre and the University of Toronto, Toronto, Ont. gkoren@sickkids.ca
Avner
Marina
M
Shear
Neil
N
D000014:Abnormalities, Drug-Induced; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D006293:Health Promotion; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012306:Risk; D013723:Teratogens
D003879:Dermatologic Agents; D013723:Teratogens; D015474:Isotretinoin